Cytokines and inflammatory mediators: Targeting specific cytokines, such as tumor necrosis factor-alpha (TNF-α), interleukin-17 (IL-17), or other key inflammatory mediators, holds promise as a potential therapeutic approach in autoimmune gastritis. The gene discussed is IL17A; the disease is autoimmune gastritis.